Daniel Janney, Director at Krystal Biotech, Inc. (KRYS), sold 50,000 shares at $95.02 ($4.8M) on 2023-05-19, disclosed to the SEC on 2023-05-23.
Scheduled sale ($4.8M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| KRYS | SELL | 2023-06-09 | $8.3M | — | Filing → |
| KRYS | SELL | 2023-05-11 | $1.6M | — | Filing → |
| KRYS | SELL | 2023-04-21 | $714K | — | Filing → |